Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Details Narrative)

v3.20.1
Common Stock (Details Narrative) - USD ($)
3 Months Ended
Jan. 09, 2020
Jan. 07, 2020
Jun. 14, 2019
Sep. 07, 2018
Mar. 31, 2020
Mar. 31, 2019
Jan. 12, 2020
Dec. 31, 2019
Common stock, shares authorized       100,000,000     100,000,000
Common stock, shares issued         41,206,632     41,125,303
Common stock, shares outstanding         41,206,632     41,125,303
Common stock, par value         $ 0.001     $ 0.001
Common stock issued for Director compensation in Volition Germany, shares 73,263              
Common stock issued for Director compensation in Volition Germany, amount $ 333,969       $ 333,969      
Common stock value         41,207     $ 41,125
Proceed from issuance of common stock         $ 6,660,671    
Stock Option [Member]                
Option exercised   12,500          
Purchase price   $ 2.35          
Issuance of cashless exercise of common stock   6,135            
Stock Option [Member] | From February 24, 2020 to March 20, 2020 [Member]                
Option exercised   8,882          
Issuance of cashless exercise of common stock   1,947            
Purchase price   $ 2.35          
Stock Option Two [Member]                
Option exercised   35,000          
Purchase price   $ 4.00          
Issuance of cashless exercise of common stock   6,486            
Stock Option One [Member]                
Option exercised   12,500          
Issuance of cashless exercise of common stock   4,862            
Purchase price   $ 3.00          
Equity Distribution Agreement [Member]                
Common stock, shares issued       3,200      
Proceed from issuance of common stock       $ 16,547      
Stock Incentive Plan [Member] | Common Stock [Member]                
Description of aggregate shares     Amendment to the 2015 Stock Incentive Plan (the "2015 Plan") was approved by the stockholders at the annual meeting to increase the number of shares of common stock available for issuance under the 2015 Plan by 1,000,000 shares to an aggregate maximum of 4,250,000 shares.          
Chief Medical Officer [Member]                
Common stock, shares purchased             11,364  
Common stock value           $ 54,434  
Common stock, purchase price           $ 4.79